CAROLINE MANN: Open Payments
NPI 1013934579 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 9 payments from 8 companies in 2025. Trend: 2023 $511 · 2024 $947 · 2025 $240
Food & beverage: $144Education: $97
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $17 |
| Organon LLC | 2 | $8 |
Products named: DUPIXENT, COSENTYX, TALTZ, LIBTAYO, CIBINQO, SKYRIZI, TREMFYA, VTAMA.
Industry payments across MO — which companies pay providers there.
